[Clinical activity and tolerance of a new pyrazolic association].
D000632:Aminopyrine / Q000008:administration & dosage / Q000627:therapeutic use*; D001777:Blood Coagulation / Q000187:drug effects; D001792:Blood Platelets / Q000187:drug effects; D004338:Drug Combinations; D004361:Drug Tolerance; D004912:Erythrocytes / Q000187:drug effects; D005260:Female; D006073:Gout / Q000188:drug therapy; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy*; D007962:Leukocytes / Q000187:drug effects; D008297:Male; D009443:Neuritis / Q000188:drug therapy; D010619:Phenazines / Q000008:administration & dosage / Q000627:therapeutic use*; D011720:Pyrazoles / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D012585:Sciatica / Q000188:drug therapy
D004338:Drug Combinations; D010619:Phenazines; D011720:Pyrazoles; D000632:Aminopyrine
Indagini sull'attività clinica e sulla tollerabilità di una nuova associazione pirazolica.